Blake Marriott

Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy

Angus G. Dalgleish, A. Dalgleish, S. Todryk, 2002, Cancer Immunology, Immunotherapy.

CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production.

S. Goodbourn, A. Dalgleish, M. Westby, 1998, Journal of immunology.

Activation-Induced TNF-Thalidomide and Potent Inhibitor of CC-3052 : A Water-Soluble Analog of

S. Goodbourn, A. Dalgleish, M. Westby, 1998 .